Pluristem Therapeutics (PSTI) Release: Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia
5/13/2013 9:34:49 AM
More...
|
Pluristem Therapeutics (PSTI) Develops PLX-RAD Cells for Use in Hematology
5/7/2013 9:48:50 AM
More...
|
Third Party Research Study Demonstrates Pluristem Therapeutics (PSTI)'s PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension
4/29/2013 11:46:40 AM
More...
|
Pluristem Therapeutics (PSTI) Obtains Orphan Drug Status for Aplastic Anemia Treatment
2/21/2013 7:13:33 AM
More...
|
Pluristem Therapeutics (PSTI) Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility
1/30/2013 9:30:05 AM
More...
|
Pluristem Therapeutics (PSTI) Updates Cell Manufacturing Industry on Its Proprietary 3D Cell Expansion Technology at Industry Conference
1/22/2013 9:10:52 AM
More...
|
Pluristem Therapeutics (PSTI) Receives Approval to Expand Its Phase II Clinical Trial in Intermittent Claudication to Germany
1/15/2013 9:20:02 AM
More...
|
Pluristem Therapeutics (PSTI)'s CEO Letter to Shareholders
1/7/2013 9:46:06 AM
More...
|
Pluristem Therapeutics (PSTI) Initiates Final Validation of New Manufacturing Facility
12/27/2012 9:13:13 AM
More...
|
Pluristem Therapeutics (PSTI) to Present at Oppenheimer 23rd Annual Healthcare Conference
12/12/2012 9:14:04 AM
More...
|
|